MKC-1

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

10 competitors in Pancreatic Cancer

Drug Information

Target Indication

Pancreatic Cancer

Clinical Trial

Last updated: 3/1/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

CASIF

CASI Pharmaceuticals, Inc.

Related Pipeline

Metastatic Renal Cell Carcinoma

Carcinoma, Non-Small-Cell Lung

Recurrent Glioblastoma Multiforme

Recurrent Glioblastoma Multiforme

Advanced Adult Hepatocellular Carcinoma

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts